IQ treatment was found to enhance LC3 expression while reducing p62, thereby inducing excessive autophagy and promoting apoptosis in ESCC cells via the AKT/mTOR signaling pathway. Here, MAP1LC3A is linked to esophageal squamous cell carcinoma.